Alzheimer’s Drug & Dermatitis JAK inhibitor Among New EU Filings
AstraZeneca’s New Lupus Treatment Is Also Under Review
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.
